Home Other Building Blocks API-2

API-2

CAS No.:
35943-35-2
Catalog Number:
AG00C0BN
Molecular Formula:
C14H18N6O3
Molecular Weight:
318.3311
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%
1 week
United States
$190
- +
10mg
98%
1 week
United States
$273
- +
50mg
98%
1 week
United States
$690
- +
100mg
98%
1 week
United States
$1190
- +
Product Description
Catalog Number:
AG00C0BN
Chemical Name:
API-2
CAS Number:
35943-35-2
Molecular Formula:
C14H18N6O3
Molecular Weight:
318.3311
MDL Number:
MFCD16879015
IUPAC Name:
(2R,3R,4S,5R)-2-(5-amino-7-methyl-2,6,7,9,11-pentazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI:
InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8-,9-,13-/m1/s1
InChI Key:
HOGVTUZUJGHKPL-HTVVRFAVSA-N
SMILES:
OC[C@H]1C[C@H]([C@@H]([C@@H]1O)O)n1cc2c3c1ncnc3n(nc2N)C
UNII:
2421HMY9N6
Properties
Complexity:
507  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
4  
Defined Bond Stereocenter Count:
0
Exact Mass:
320.123g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
320.309g/mol
Monoisotopic Mass:
320.123g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
142A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.6  
Literature
Title Journal
Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicology in vitro : an international journal published in association with BIBRA 20180301
Why are most phospholipidosis inducers also hERG blockers? Archives of toxicology 20171201
Insulin attenuates arsenic-induced neurite outgrowth impairments by activating the PI3K/Akt/SIRT1 signaling pathway. Toxicology letters 20150805
Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression. International journal of molecular medicine 20131001
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. The Biochemical journal 20130415
Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology 20130201
Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient mice. Resuscitation 20121101
Exercise training and PI3Kα-induced electrical remodeling is independent of cellular hypertrophy and Akt signaling. Journal of molecular and cellular cardiology 20121001
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer. Cancer research 20120901
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer discovery 20120701
Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia. Translational research : the journal of laboratory and clinical medicine 20120601
AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors. International journal of oncology 20120301
Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells. Toxicology 20120226
FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer. PloS one 20120101
IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. The Journal of biological chemistry 20111028
AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biological psychiatry 20110915
Akt increases sox2 expression in adult hippocampal neural progenitor cells, but increased sox2 does not promote proliferation. Stem cells and development 20110701
JAM-A regulates epithelial proliferation through Akt/β-catenin signalling. EMBO reports 20110401
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia. Journal of cellular physiology 20110301
Insulin up-regulates heme oxygenase-1 expression in 3T3-L1 adipocytes via PI3-kinase- and PKC-dependent pathways and heme oxygenase-1-associated microRNA downregulation. Endocrinology 20110201
1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. The Prostate 20101101
Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef. Antimicrobial agents and chemotherapy 20100401
Sensitivity of cardiac carnitine palmitoyltransferase to malonyl-CoA is regulated by leptin: similarities with a model of endogenous hyperleptinemia. Endocrinology 20100301
Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle. Molecular and cellular endocrinology 20100205
Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin. Peptides 20100101
A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB. PloS one 20100101
1-Nitropyrene stabilizes the mRNA of cytochrome P450 1a1, a carcinogen-metabolizing enzyme, via the Akt pathway. Chemical research in toxicology 20091201
Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy. European journal of obstetrics, gynecology, and reproductive biology 20090901
The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. International journal of cancer 20090815
Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D. Gene therapy 20090401
[Akt enzyme: new therapeutic target in cancer and diabetes?]. Orvosi hetilap 20090222
High-throughput screening compatible cell-based assay for interrogating activated notch signaling. Assay and drug development technologies 20090201
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. The Biochemical journal 20090101
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry 20081113
Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. Journal of cellular physiology 20081101
The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine. Bioorganic & medicinal chemistry 20080901
Endosomal colocalization of melanocortin-3 receptor and beta-arrestins in CAD cells with altered modification of AKT/PKB. Neuropeptides 20080601
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer research 20080115
Resistin, an adipocytokine, offers protection against acute myocardial infarction. Journal of molecular and cellular cardiology 20071101
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency. Clinical cancer research : an official journal of the American Association for Cancer Research 20071001
Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines. Biochemical and biophysical research communications 20060210
Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Current opinion in investigational drugs (London, England : 2000) 20051201
Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine. Journal of medicinal chemistry 20050602
Synthesis of new 2'-beta-C-methyl related triciribine analogues as anti-HCV agents. Bioorganic & medicinal chemistry letters 20040705
An improved total synthesis of triciribine: a tricyclic nucleoside with antineoplastic and antiviral properties. Nucleosides, nucleotides & nucleic acids 20040101
Synthesis and antiviral activity of 2-substituted analogs of triciribine. Nucleosides, nucleotides & nucleic acids 20031201
Synthesis of carbocyclic analogs of 2',3'-dideoxysangivamycin, 2',3'-dideoxytoyocamycin, and 2',3'-dideoxytriciribine. Nucleosides, nucleotides & nucleic acids 20010101
Deoxy sugar analogues of triciribine: correlation of antiviral and antiproliferative activity with intracellular phosphorylation. Journal of medicinal chemistry 20000615
Phosphorylation of triciribine is necessary for activity against HIV type 1. AIDS research and human retroviruses 19981010
Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2. AIDS research and human retroviruses 19930401
Dual mechanisms of inhibition of DNA synthesis by triciribine. Cancer research 19900815
Properties